Paper Details

  1. Home
  2. Paper Details

Levonorgestrel intrauterine system for the treatment of intermenstrual spotting in patients with previous cesarean delivery scar defect.

Author: ChenYing-Yi, ChengLing-Yun, ChuLi-Ching, LanKuo-Chung, OuYu-Che, TsaiChing-Chang

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Levonorgestrel 52 mg intrauterine system was safe and effective in managing intermenstrual spotting in patients with previous cesarean delivery scar defects (PCDSs).
Paper Details　
Original Abstract of the Article :
AIM: To evaluate the efficacy of levonorgestrel 52 mg intrauterine system for intermenstrual bleeding in patients with previous cesarean delivery scar defects (PCDSs). METHODS: The medical records of 28 consecutive patients with previous cesarean delivery scar defect and intermenstrual bleeding who...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1111/jog.15062

データ提供：米国国立医学図書館（NLM）

A New Hope for Intermenstrual Spotting: Levonorgestrel Intrauterine System

Intermenstrual spotting, like a persistent desert mirage, can be a frustrating and challenging experience for women. This study explores the effectiveness of levonorgestrel 52 mg intrauterine system in treating intermenstrual bleeding in patients with previous cesarean delivery scar defects (PCDSs). The researchers sought to find a safe and effective solution to a common and often overlooked gynecological issue.

Levonorgestrel Intrauterine System: A Promising Solution

The study reveals that levonorgestrel intrauterine system holds promise as a safe and effective treatment for intermenstrual spotting in patients with PCDSs. A significant majority of patients reported improvement in symptoms after one year of treatment, with a notable reduction in the duration of menstruation. This is a significant finding, offering hope to patients struggling with this condition.

A Beacon of Hope for Women's Health

This study provides a beacon of hope for women experiencing intermenstrual spotting, especially those with PCDSs. The levonorgestrel intrauterine system offers a minimally invasive and effective treatment option, potentially improving quality of life and reducing the burden of this often-neglected condition. This research, like a refreshing oasis in the desert, offers a potential solution to a common and often challenging gynecological issue.

Dr.Camel's Conclusion

This research, like a camel navigating the vast desert of gynecological challenges, highlights the potential of levonorgestrel intrauterine system as a safe and effective treatment for intermenstrual spotting in women with PCDSs. The study's findings offer a glimmer of hope for those struggling with this condition, suggesting a path toward improved quality of life and reduced menstrual discomfort. Just as we learn to appreciate the resilience of life in the desert, we must continue to explore innovative solutions for women's health concerns.

Date :
  1. Date Completed 2022-01-04
  2. Date Revised 2022-01-04
Further Info :

Pubmed ID

34734462

DOI: Digital Object Identifier

10.1111/jog.15062

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.